Letermovir prophylaxis reduces the risk for CMV reactivation after allogeneic stem cell transplantation

被引：0
|
作者：
Koch, K. [1 ]
Herhaus, P. [1 ]
Osswald, L. [1 ]
Braitsch, K. [1 ]
Bassermann, F. [1 ]
Verbeek, M. [1 ]
机构：
[1] Tech Univ Munich, Munich, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2021年 / 44卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
V639
引用
下载
收藏
页码：62 / 62
页数：1
相关论文
共 50 条
  • [21] Letermovir Prophylaxis For Cytomegalovirus Reactivation in Allogeneic Stem Cell Transplantation: A Multicenter Italian Real-world Experience
    Paviglianiti, Annalisa
    Pitino, Annalisa
    Carella, Angelo Michele, Jr.
    Bruno, Benedetto
    Crescimanno, Alessandra
    Federico, Vincenzo
    Picardi, Alessandra
    Tringali, Stefania
    Ingrosso, Claudia
    Carluccio, Paola
    Pastore, Domenico
    Vacca, Adriana
    Serio, Bianca
    Storti, Gabriella
    Mordini, Nicola
    Leotta, Salvatore
    Cimminiello, Michele
    Prezioso, Lucia
    Loteta, Barbara
    Ferreri, Anna
    Colasante, Fabrizia
    Merla, Emanuela
    Giaccone, Luisa
    Busca, Alessandro
    Musso, Maurizio
    Scalone, Renato
    Di Renzo, Nicola
    Marotta, Serena
    Mazza, Patrizio
    Musto, Pellegrino
    Attolico, Immacolata
    Selleri, Carmine
    Gori, Mercedes
    Tripepi, Giovanni
    Porto, Gaetana
    Martino, Massimo
    BONE MARROW TRANSPLANTATION, 2021, 56 (SUPPL 1) : 98 - 99
  • [22] High Dose Valaciclovir As CMV Prophylaxis in Allogeneic Hematopoietic Stem Cell Recipients at High Risk of CMV Reactivation
    Douglas, Genevieve
    Yong, Michelle K.
    Tio, Shio Yen
    Chau, Maggie
    Sasadeusz, Joe
    Slavin, Monica
    Xie, Mingdi
    Ritchie, David
    Chee, Lynette C. Y.
    BLOOD, 2020, 136
  • [23] RISK FACTORS OF CMV-REACTIVATION AND THE INFLUENCE OF CMV-REACTIVATION ON RISK OF LEUKEMIA RELAPSE IN CHILDREN AND ADOLESCENTS AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
    Shiriaev, S.
    Chukhlovin, A.
    Vavilov, V.
    Stancheva, N.
    Barkhatov, I.
    Zubarovskaya, L.
    Afanasyev, B.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S463 - S463
  • [24] Efficacy of CMV prophylaxis with letermovir early after transplantation
    Satake, Atsushi
    Hotta, Masaaki
    Saito, Ryo
    Konishi, Akiko
    Yoshimura, Hideaki
    Nakanishi, Takahisa
    Fujita, Shinya
    Ito, Tomoki
    Ishii, Kazuyoshi
    Nomura, Shosaku
    BONE MARROW TRANSPLANTATION, 2019, 54 : 448 - 448
  • [25] How I treat CMV reactivation after allogeneic hematopoietic stem cell transplantation
    Einsele, Hermann
    Ljungman, Per
    Boeckh, Michael
    BLOOD, 2020, 135 (19) : 1619 - 1629
  • [26] Correction: CMV prophylaxis with letermovir significantly improves graft and relapse free survival following allogeneic stem cell transplantation
    Michele Malagola
    Vera Radici
    Mirko Farina
    Simone Pellizzeri
    Filippo Spoldi
    Enrico Morello
    Nicola Polverelli
    Eugenia Accorsi Buttini
    Simona Bernardi
    Federica Re
    Alessandro Leoni
    Liana Signorini
    Arnaldo Caruso
    Domenico Russo
    Bone Marrow Transplantation, 2024, 59 (2) : 293 - 293
  • [27] A Mortality Analysis of Letermovir Prophylaxis for Cytomegalovirus (CMV) in CMV-seropositive Recipients of Allogeneic Hematopoietic Cell Transplantation
    Ljungman, Per
    Schmitt, Michael
    Marty, Francisco M.
    Maertens, Johan
    Chemaly, Roy F.
    Kartsonis, Nicholas A.
    Butterton, Joan R.
    Wan, Hong
    Teal, Valerie L.
    Sarratt, Kendra
    Murata, Yoshihiko
    Leavitt, Randi Y.
    Badshah, Cyrus
    CLINICAL INFECTIOUS DISEASES, 2020, 70 (08) : 1525 - 1533
  • [28] CMV-IgG pre-allogeneic hematopoietic stem cell transplantation and the risk for CMV reactivation and mortality
    Eberhardt, Kirsten Alexandra
    Jung, Verena
    Knops, Elena
    Heger, Eva
    Wirtz, Maike
    Steger, Gertrud
    Kaiser, Rolf
    Affeldt, Patrick
    Holtick, Udo
    Klein, Florian
    Scheid, Christof
    Di Cristanziano, Veronica
    BONE MARROW TRANSPLANTATION, 2023, 58 (06) : 639 - 646
  • [29] CMV-IgG pre-allogeneic hematopoietic stem cell transplantation and the risk for CMV reactivation and mortality
    Kirsten Alexandra Eberhardt
    Verena Jung
    Elena Knops
    Eva Heger
    Maike Wirtz
    Gertrud Steger
    Rolf Kaiser
    Patrick Affeldt
    Udo Holtick
    Florian Klein
    Christof Scheid
    Veronica Di Cristanziano
    Bone Marrow Transplantation, 2023, 58 : 639 - 646
  • [30] Valganciclovir for the prophylaxis of early cytomegalovirus (CMV) infection after allogeneic stem cell transplantation
    Bachier, C
    Shaughnessy, P
    Wall, D
    Grimley, M
    Carrum, G
    Freytes, C
    Callander, N
    Walsh, T
    LeMaistre, CF
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2005, 11 (02) : 90 - 91
12345